Enhanced treatment helps fast nicotine metabolizers quit smoking
A study from Vanderbilt researchers has found that enhanced treatment support can help smokers who have more difficulty quitting because they are fast metabolizers of nicotine.
Treating delirium detected in the ED
Delirium — a form of acute brain failure — affects 8-17% of older adults who present to the emergency department (ED). It is associated with adverse outcomes including higher health care use, accelerated functional decline, and increased mortality.
Vanderbilt Diabetes Day celebrates investigational achievements, looks toward future
Vanderbilt Diabetes Day, an annual event that showcases the work of outstanding scientists and researchers in the fields of diabetes, obesity and metabolism was held this month, and it marked the first time many investigators working under the auspices of the Vanderbilt Diabetes Research and Training Center (DRTC) had gathered in one space since the beginning of the COVID-19 pandemic.
Tindle authors NCI guidance on treatment of cancer patient who smoke
The new Tobacco Control Monograph from the National Cancer Institute (NCI) has key contributions f